Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Safety and Efficacy of Idelalisib Treatment of Chronic Lymphocytic Leukemia (CLL) or Lymphoma Relapsing after Allogeneic Hematopoietic Cell Transplantation (alloHCT): A Survey By the EBMT Chronic Malignancies and Lymphoma Working Parties

Blood (2017) 130 (Supplement 1): 3273.

https://doi.org/10.1182/blood.V130.Suppl_1.3273.3273

Published: 2017

Journal Articles

Single-Agent Ibrutinib Vs Chemoimmunotherapy Regimens for Treatment-Naïve Patients with Chronic Lymphocytic Leukemia (CLL): A Cross-Trial Comparison

Blood (2017) 130 (Supplement 1): 1750.

https://doi.org/10.1182/blood.V130.Suppl_1.1750.1750

Published: 2017

Journal Articles

Loss of Imprinting at the 14q32 Domain Leads to MicroRNA Overexpression in Acute Promyelocytic Leukemia

Floriana Manodoro, PhD, Jacek Marzec, Jun Wang, PhD, Tracy Chaplin, Jelena V Jovanovic, Moravcsik Eva, Iqbal Sameena, David Grimwade, MD, PhD, John Gribben, MD, DSc, Bryan D Young, BSc, PhD, Silvana Debernardi, PhD

Blood (2013) 122 (21): 2494.

https://doi.org/10.1182/blood.V122.21.2494.2494

Published: 2013

Journal Articles

Arginine Deprivation With Pegylated Arginine Deiminase Induces Death Of Acute Myeloid Leukaemia Cells In Vivo

Farideh Miraki-Moud, PhD, Linda Ariza-McNaughton, MSc, Essam A Ghazaly, MD, Katharine A Hodby, Phuong Luong, Andrew Clear, PhD, Fareeda Sohrabi, John Bomalaski, John Gribben, MD, DSc, Dominique Bonnet, PhD, Peter Szlosarek, David C Taussig, PhD, MRCP, FRCPath

Blood (2013) 122 (21): 1458.

https://doi.org/10.1182/blood.V122.21.1458.1458

Published: 2013

Journal Articles

Psychosocial Factors and Impact Of Cancer In British Long-Term Haematological Cancer Survivors

Ania Korszun, PhD, MD, FRCPsych, Shah-Jalal Sarker, PhD, FHEA, Kashfia Chowdhury, MSc, Charlotte Clark, PhD, CPsychol, Paul Greaves, MD, Rachel Johnson, Judith Kingston, Gill Levitt, MD, FRPCh, Janet Matthews, Peter White, MD, FRCP, FRCPscyh, Andrew Lister, John Gribben, MD, DSc

Blood (2013) 122 (21): 2943.

https://doi.org/10.1182/blood.V122.21.2943.2943

Published: 2013

Journal Articles

Trisomy 12 CLL Cells Have High Surface Expression Of Integrins Involved In Lymphocyte Trafficking But This Does Not Translate Into Improved LFA-1-Mediated Motility

Conor J. O'Donovan, Alan G. Ramsay, PhD, Fabienne McClanahan, MD, Laura Rassenti, PhD, Thomas J. Kipps, MD, PhD, John Gribben, MD, DSc, John C. Riches, MD

Blood (2013) 122 (21): 4159.

https://doi.org/10.1182/blood.V122.21.4159.4159

Published: 2013

Journal Articles

Intraclonal Complexity Of CLL Fractions In Cell Proliferation Rates, Gene Expression Signatures, and Responses To Autologous T-Cell Help In Peripheral blood and Secondary Lymphoid Tissues

Shih-Shih Chen, Thomas M. Herndon, MD, Claire Emson, PhD, John C. Riches, MD, Fabienne McClanahan, MD, Timothy Tong, Xiao-Jie Yan, MD PhD, Piers E.M. Patten, MD, PhD, John Gribben, MD, DSc, Adrian Wiestner, MD, PhD, Nicholas Chiorazzi, MD

Blood (2013) 122 (21): 115.

https://doi.org/10.1182/blood.V122.21.115.115

Published: 2013

Journal Articles

T-Cell Dysfunction In CLL Is Mediated Not Only By PD-1/PD-L1 But Also By PD-1/PD-L2 Interactions - Partial Functionality Is Maintained In PD-1 Defined CD8 Subsets and This Can Be Further Promoted By Ibrutinib Treatment

Fabienne McClanahan, MD, Shaun Miller, John C. Riches, MD, Essam Ghazaly, MD, PhD, William P. Day, Melania Capasso, PhD, John Gribben, MD, DSc

Blood (2013) 122 (21): 4120.

https://doi.org/10.1182/blood.V122.21.4120.4120

Published: 2013

Journal Articles

NK Cells From CLL Patients Exhibit Down-Regulation Of Interferon Response Genes That Can Be Reversed With Lenalidomide

John C. Riches, MD, Ajanthah Sangaralingam, PhD, Tracy Chaplin, Fabienne McClanahan, MD, Sameena Iqbal, Samir G. Agrawal, Alan G. Ramsay, PhD, John Gribben, MD, DSc

Blood (2013) 122 (21): 4131.

https://doi.org/10.1182/blood.V122.21.4131.4131

Published: 2013

Journal Articles

High Frequency of Surface Immunoglobulin IgG in B-Cell Chronic Lymphocytic Leukaemia.

Catherine Wiseman, BSc, Jerome Giustiniani, PhD, Lene Mikkelsen, MSc, Marion Macey, PhD, Lindsey Goff, PhD, John Gribben, MD, PhD, Samir Agrawal, MD, PhD

Blood (2007) 110 (11): 4685.

https://doi.org/10.1182/blood.V110.11.4685.4685

Published: 2007

Journal Articles

HLA-C Mismatch Is Associated with Inferior Outcome after Unrelated Donor Non-Myeloablative Hematopoietic Stem Cell Transplantation.

Vincent T. Ho, MD, Haesook T. Kim, PhD, Sarah Windawi, Deborah Liney, Edgar Milford, MD, John Gribben, MD, Corey Cutler, MD, MPH, FRCP, Stephanie J. Lee, MD, MPH, Joseph H. Antin, MD, Robert J. Soiffer, MD, Edwin P. Alyea, MD

Blood (2005) 106 (11): 835.

https://doi.org/10.1182/blood.V106.11.835.835

Published: 2005

Journal Articles

Similar Outcome of Non-Myeloablative and Myeloablative Allogeneic Hematopoietic Cell Transplantation for Patients Greater Than Fifty Years of Age.

Edwin P. Alyea, MD, Haesook Kim, PhD, Corey Cutler, MD, Vincent T. Ho, MD, John Gribben, MD, PhD, Daniel J. DeAngelo, MD, Stephanie J. Lee, MD, Sarah Windawi, Richard Stone, MD, Jerome Ritz, MD, Joseph H. Antin, MD, Robert J. Soiffer, MD

Blood (2004) 104 (11): 300.

https://doi.org/10.1182/blood.V104.11.300.300

Published: 2004

Journal Articles

Phase 2 Study of Three Doses of Single Agent Bortezomib in Patients with Fludarabine-Refractory B-Cell CLL.

Stefan Faderl, MD, Kanti R. Rai, MD, John Gribben, MD, Ian Flinn, MD, John C. Byrd, MD, David McConkey, PhD, David Schenkein, MD, Dixie Esseltine, MD, Mary L. Browning, RN, Michael J. Keating, MD

Blood (2004) 104 (11): 4841.

https://doi.org/10.1182/blood.V104.11.4841.4841

Published: 2004

Journal Articles

High Levels of Donor Chimerism Early after Non-Myeloablative Transplantation Predictive of Overall and Progression Free Survival but Not Risk of Acute Graft Versus Host Disease for Patients with AML or MDS.

Edwin P. Alyea, MD, Shuli Li, MS, Haesook Kim, PhD, Vincent T. Ho, MD, Corey Cutler, MD, Stephanie J. Lee, MD, John Gribben, MD, Richard M. Stone, MD, Daniel J. DeAngelo, MD, Jerome Ritz, MD, Joseph H. Antin, MD, Robert J. Soiffer, MD

Blood (2004) 104 (11): 185.

https://doi.org/10.1182/blood.V104.11.185.185

Published: 2004

Journal Articles

Sirolimus, Tacrolimus and Reduced-Dose Methotrexate as Graft Versus Host Disease (GVHD)Prophylaxis after Non-Myeloablative Stem Cell Transplantation: Low Incidence of Acute GVHD Compared with Tacrolimus/Methotrexate or Cyclosporine/Prednisone.

Edwin P. Alyea, MD, Shuli Li, MS, Haesook Kim, PhD, Corey Cutler, MD, Vincent Ho, MD, Stephanie J. Lee, MD, John Gribben, MD, PhD, Jerome Ritz, MD, David C. Fisher, MD, Robert J. Soiffer, MD, Joseph H. Antin, MD

Blood (2004) 104 (11): 730.

https://doi.org/10.1182/blood.V104.11.730.730

Published: 2004

NARROW

Safety and Efficacy of Idelalisib Treatment of Chronic Lymphocytic Leukemia (CLL) or Lymphoma Relapsing after Allogeneic Hematopoietic Cell Transplantation (alloHCT): A Survey By the EBMT Chronic Malignancies and Lymphoma Working Parties

Single-Agent Ibrutinib Vs Chemoimmunotherapy Regimens for Treatment-Naïve Patients with Chronic Lymphocytic Leukemia (CLL): A Cross-Trial Comparison

Loss of Imprinting at the 14q32 Domain Leads to MicroRNA Overexpression in Acute Promyelocytic Leukemia

Arginine Deprivation With Pegylated Arginine Deiminase Induces Death Of Acute Myeloid Leukaemia Cells In Vivo

Psychosocial Factors and Impact Of Cancer In British Long-Term Haematological Cancer Survivors

Trisomy 12 CLL Cells Have High Surface Expression Of Integrins Involved In Lymphocyte Trafficking But This Does Not Translate Into Improved LFA-1-Mediated Motility

Intraclonal Complexity Of CLL Fractions In Cell Proliferation Rates, Gene Expression Signatures, and Responses To Autologous T-Cell Help In Peripheral blood and Secondary Lymphoid Tissues

T-Cell Dysfunction In CLL Is Mediated Not Only By PD-1/PD-L1 But Also By PD-1/PD-L2 Interactions - Partial Functionality Is Maintained In PD-1 Defined CD8 Subsets and This Can Be Further Promoted By Ibrutinib Treatment

NK Cells From CLL Patients Exhibit Down-Regulation Of Interferon Response Genes That Can Be Reversed With Lenalidomide

High Frequency of Surface Immunoglobulin IgG in B-Cell Chronic Lymphocytic Leukaemia.

HLA-C Mismatch Is Associated with Inferior Outcome after Unrelated Donor Non-Myeloablative Hematopoietic Stem Cell Transplantation.

Similar Outcome of Non-Myeloablative and Myeloablative Allogeneic Hematopoietic Cell Transplantation for Patients Greater Than Fifty Years of Age.

Phase 2 Study of Three Doses of Single Agent Bortezomib in Patients with Fludarabine-Refractory B-Cell CLL.

High Levels of Donor Chimerism Early after Non-Myeloablative Transplantation Predictive of Overall and Progression Free Survival but Not Risk of Acute Graft Versus Host Disease for Patients with AML or MDS.

Sirolimus, Tacrolimus and Reduced-Dose Methotrexate as Graft Versus Host Disease (GVHD)Prophylaxis after Non-Myeloablative Stem Cell Transplantation: Low Incidence of Acute GVHD Compared with Tacrolimus/Methotrexate or Cyclosporine/Prednisone.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only